Raqia Therapeutics

0 followers


Raqia Therapeutics is an exciting startup company developing a transformative chimeric antigen receptor (CAR) technology for immunotherapy. At Raqia Therapeutics, they are motivated to bring life-changing therapy to patients with cancer.

Industries

Employees

1-10

Links

Org chart

Fred Mermelstein
Co-Founder, CEO & President

Fred Mermelstein

Collapse
Julia A. Novina
Co-Founder & Chief Legal Officer
John Newcomb
Head of Drug Discovery
Stephanie Kwei
Project Manager & Clinical Affairs
Alberto Nobili
Co-founder & Scientific Director
Jun Ren
Scientific Director